Home
About
Overview
Sharing Data
ORCID
Help
History (15)
Principal Investigator
Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor.
Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantation.
Expression and polymorphism (rs4880) of mitochondrial superoxide dismutase (SOD2) and asparaginase induced hepatotoxicity in adult patients with acute lymphoblastic leukemia.
Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia.
Impact of Age on Pharmacogenomics and Treatment Outcomes of B-Cell Acute Lymphoblastic Leukemia. J Clin Oncol. 2024 Oct 10; 42(29):3478-3490.
View in:
PubMed
subject areas
Adolescent
Adult
Age Factors
Aged
Antineoplastic Agents
Child
Child, Preschool
Female
Humans
Infant
Male
Middle Aged
Pharmacogenetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
Treatment Outcome
Young Adult
authors with profiles
Caner Saygin
Wendy Stock